Effectiveness of interferon treatment for patients with chronic hepatitis C virus infection and normal aminotransferase levels

被引:14
作者
Ohmiya, M
Hayashi, J [1 ]
Ueno, K
Furusyo, N
Sawayama, Y
Kawakami, Y
Kinukawa, N
Kashiwagi, S
机构
[1] Kyushu Univ Hosp, Dept Gen Med, Higashi Ku, Fukuoka 8128582, Japan
[2] Kyushu Univ Hosp, Dept Med Informat, Fukuoka 8128582, Japan
关键词
hepatitis C virus; chronic hepatitis C; normal alanine aminotransferase level; interferon-alpha;
D O I
10.1023/A:1005502816216
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
To determine the effects of interferon treatment, we studied 77 Japanese patients with hepatitis C virus (HCV) infection and normal alanine aminotransferase (ALT). Of 77 patients, 37 were given natural interferon-alpha for 24 weeks, and 40 not given interferon acted as controls. Serum samples were tested for HCV RNA and genotypes by polymerase chain reaction (PCR).HCV RNA levels were measured by competitive PCR. Of 37 treated patients, 11 (29.7%) had sustained elimination throughout a six-month follow-up, while HCV RNA was not eliminated in any untreated patients. At 24 months, the number of patients with elevated ALT was not significantly different between treated (13.5%) and untreated patients (15%). Interferon eliminates HCV RNA in patients with normal ALT without severe side effects. The natural history of HCV infection should be clarified so that the interferon treatment regimen can be tailored to the needs of each patient.
引用
收藏
页码:1953 / 1958
页数:6
相关论文
共 50 条
[41]   Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection [J].
Willems, M ;
Munte, K ;
Vrolijk, JM ;
Den Hollander, JC ;
Böhm, M ;
Kemmeren, MH ;
De Man, RA ;
Brouwer, JT .
BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 (02) :390-394
[42]   Efficacy and tolerability of low-dose interferon-α in hemodialysis patients with chronic hepatitis C virus infection [J].
Kai-Li Wang ;
Han-Qian Xing ;
Hong Zhao ;
Jun-Wei Liu ;
Deng-Lian Gao ;
Xue-Hua Zhang ;
Hong-Yu Yao ;
Li Yan ;
Jun Zhao .
World Journal of Gastroenterology, 2014, (14) :4071-4075
[43]   INTERFERON THERAPY IN CHRONIC HEPATITIS-C VIRUS-INFECTION [J].
WEILAND, O .
FEMS MICROBIOLOGY REVIEWS, 1994, 14 (03) :279-288
[44]   Amantadine in treatment of chronic hepatitis C virus infection? [J].
Lim, JK ;
Wooten, D ;
Siegel, R ;
Cheung, RC .
JOURNAL OF VIRAL HEPATITIS, 2005, 12 (05) :445-455
[45]   Pulmonary hazards of chronic hepatitis C virus infection treatment with Pegylated interferon and ribavirin vs. untreated patients [J].
Elhelaly, Sanaa ;
Elgazzar, Alaa Eldin. M. ;
Ragab, Mostafa ;
Elkomy, Howida ;
Fathy, Talaat .
EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2013, 62 (02) :325-329
[46]   Treatment optimization in chronic hepatitis C virus infection [J].
Fernandez Rodriguez, Conrado M. ;
Alonso Lopez, Sonia .
GASTROENTEROLOGIA Y HEPATOLOGIA, 2010, 33 (02) :119-125
[47]   Treatment strategies for chronic hepatitis C virus infection [J].
Kasahara, A .
JOURNAL OF GASTROENTEROLOGY, 2000, 35 (06) :411-423
[48]   Treatment of chronic hepatitis C virus infection in children [J].
Chang, MH .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2000, 14 (02) :341-350
[49]   Treatment of chronic hepatitis C with α-interferon plus ofloxacin in patients not responding to α-interferon alone [J].
Negro, F ;
Male, PJ ;
Perrin, L ;
Giostra, E ;
Hadengue, A .
JOURNAL OF HEPATOLOGY, 1998, 29 (03) :369-374
[50]   Interferon treatment of cirrhotic patients with chronic hepatitis C [J].
Idilman, R ;
DeMaria, N ;
Colantoni, A ;
Dokmeci, A ;
VanThiel, DH .
JOURNAL OF VIRAL HEPATITIS, 1997, 4 (02) :81-91